Join us for the 7th Annual diaTribe Musings Panel Discussions
Past Event: Thursday, November 3, 2022
5:30-6:45pm EDT / 2:30-3:45pm PDT
People with diabetes live with the anxiety of developing many different health complications. Among the most serious are diabetic eye diseases that can cause blindness and circulatory problems that can lead to lower limb amputation – both of which disproportionately impact the most vulnerable populations. Fortunately, scientists are developing new therapies to treat these complications, saving vision and preventing amputations.
Join this panel to hear from experts in both these areas who are treating people with diabetes and developing the new therapies that are dramatically improving outcomes. You'll also learn critical information about how to speak to your healthcare team about these complications and how to prevent them.
Panel discussion with Q&A from 5:30-6:45pm EDT / 2:30-3:45pm PDT, with Community Networking and Expo Booths open beginning 15 minutes prior. Community Networking and Expo Booths will also remain open following the panel.
Manuel Amador, MD
Medical Director, Medical Affairs Ophthalmology at Genentech
Dr. Manuel Amador is an ophthalmologist and holds the position of Medical Director, Medical Affairs Ophthalmology at Genentech. He received his medical degree at the Universidad Javeriana and specialization in ophthalmology at the Barraquer Ophthalmology School, both in Bogota, Colombia. He completed the Retina Fellowship at the Shiley Eye Institute, University of California San Diego. Since joining the medical affairs team at Genentech, he has worked on evidence generation for the Faricimab program. Dr. Amador is skilled in retina imaging, management of ocular surface diseases, inflammatory, and autoimmune and systemic diseases affecting the eye. He is also a clinical epidemiologist with experience in analytical literature review, protocol design, data management and biostatistics. Other areas he focuses on are diabetic retinopathy and improving diversity and inclusion in clinical trials.
Richard Browne, MD, FACC
Senior Medical Executive, Health Systems Strategy for Janssen Pharmaceutical Cardiovascular and Metabolism (CVM) Therapeutic Area
An experienced cardiologist, Dr. Richard Browne joined Johnson and Johnson in 2021 and since then, has led its CVM Health Equity Task Force and served as a co-lead of the Medical and Scientific Affairs Race to Health Equity pillar. Richard graduated cum laude with a medical degree from Boston University School of Medicine and completed his internship and residency at Brigham and Women’s Hospital, a major teaching hospital of Harvard Medical School, where he also joined the staff as an attending physician. He completed his fellowship in cardiovascular medicine at the University of Virginia, serving as chief cardiology fellow in his final year. Richard subsequently practiced and held leadership positions at large healthcare systems. Richard currently serves as a council member of the North Carolina Chapter of the American College of Cardiology. In this position, he is actively involved in the formulation of strategies to reduce health care disparities in cardiovascular patients.
Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP
Endocrinology Clinical Pharmacy Specialist and the Continuous Glucose Monitoring Program Coordinator at the Cleveland Clinic Endocrinology and Metabolism Institute
Dr. Isaacs earned her bachelor’s degree in Chemistry from the University of Illinois at Chicago, Doctor of Pharmacy Degree from Southern Illinois University Edwardsville. Dr. Isaacs holds board certifications in pharmacotherapy, ambulatory care, and advanced diabetes management. She serves on the American Diabetes Association (ADA) Professional Practice Committee, the committee that updates the ADA Standards of Care. She is also a National Board Member of the Association of Diabetes Care and Education Specialists (ADCES). She advocates access and choice to the latest technologies and therapeutics for all people with diabetes and speaks on diabetes related topics nationally and internationally. Dr. Isaacs is a Fellow in ADCES and the American College of Clinical Pharmacy (ACCP). She was the ADCES Diabetes Care and Education Specialist of the Year in 2020
Paolo S. Silva, MD
Ophthalmologist and Co-chief of Telemedicine at Beetham Eye Institute, Joslin Diabetes Center; Associate Professor, Ophthalmology at Harvard Medical School
Dr. Paolo Silva’s work is focused on innovative and investigative work in a field that is at the intersection of clinical care and technology with the hope of providing an ideal model for the delivery of evidence-based highly effective and efficient diabetes eye care to the population that needs it the most. With over 129 scientific publications to his name, Dr. Silva’s primary expertise lies in the fields of ocular telehealth for diabetic retinopathy, ultrawide field retinal imaging and artificial intelligence applications. His work and efforts have been recognized with more than 29 national and international awards that include Young Clinician Award from the Center for Integration of Medicine and Innovative Technology at Harvard Medical School and the Achievement Award from the American Academy of Ophthalmology. He has been awarded by the UK Newton Fund and the Philippine Department of Science and Technology to evaluate cost-effective solutions for diabetic retinopathy evaluation in the Philippines.
Senior Director of Time in Range Coalition, The diaTribe Foundation
Julie Heverly has devoted that last decade of her career to the diabetes ecosystem in progressive leadership roles at the American Diabetes Association and currently with The diaTribe Foundation. She was diagnosed with type 1 diabetes after her junior year at Washington & Jefferson College. After graduation, she provided public affairs and PR counsel to clients like the Eisenhower Presidential Museum, The National Center for Victims of Crime, and Americans for Alaska. She eventually earned a position at Burson Marsteller, where she consulted a Fortune 500 company on government and community affairs. Compelled by her own experiences navigating a non-traditional diagnosis and journey with type 1 diabetes, Julie has become a patient advocate and champion, adding her voice to local and national social media campaigns and providing patient perspective with the hope of improving the lives of others also living with diabetes. At The diaTribe Foundation Julie coordinates the Time in Range Coalition, composed of 26 organizations working collaboratively to improve the lives of people with diabetes by advancing Time In Range as the primary glucose metric for daily management, complemented by A1C, in diabetes care globally.
About diaTribe Musings
Previously known as Musings Under the Moon, when it was a single live event at the ADA Scientific Sessions, diaTribe Musings is now one of The diaTribe Foundation's most treasured ongoing virtual programs, engaging a diverse audience in thought-provoking dialogue and providing an opportunity to connect healthcare providers, business leaders, people living with diabetes, advocates, families, entrepreneurs, and policymakers. Musings tickets are complimentary thanks to the generous support of our sponsors. We welcome anyone interested in learning about the massive shifts and opportunities occurring in the world of diabetes. Please spread the word and share this event with anyone interested in learning more about diabetes. Join the conversation on Twitter with #diaTribeMusings.
Past Musings Events